Drug intelligence / Profile preview

polyethylene glycol + linaclotide

Development stage
Unknown
Lead developer
Ironwood Pharmaceuticals
Modality
Peptides, Small Molecules
Administration
Oral
01

Overview

Polyethylene glycol + linaclotide is a combination regimen used primarily for bowel preparation prior to colonoscopy, especially in patients with chronic constipation or irritable bowel syndrome. Polyethylene glycol (PEG) is an osmotic laxative that retains water in the stool, resulting in softer stools and increased bowel movements. Linaclotide is a guanylate cyclase-C agonist that increases intestinal fluid secretion and accelerates transit by stimulating cyclic GMP production on the luminal surface of the intestinal epithelium. The combination aims to improve both efficacy and tolerability of bowel cleansing compared to high-volume PEG alone, offering similar or superior cleansing quality with reduced adverse effects such as abdominal discomfort, bloating, nausea, and vomiting[1][2][3][4][5][6].

Other names
polyethylene glycol + linaclotide
02

Targets

GUCY2C (Guanylate cyclase C receptor)

Beyond the preview

Go deeper on polyethylene glycol + linaclotide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on polyethylene glycol + linaclotide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call